CALPRO Calprotectin ELISA Test (ALP): CE-marked

The CALPRO Calprotectin ELISA Test (ALP) is a quantitative method for the determination of Calprotectin in stool samples and can be used as an aid in identifying organic disease of the small intestine, large bowel or the stomach in patients, to determine the disease activity and monitor the response to treatment in patients with ulcerative colitis or Crohn’s disease. In the literature Calprotectin determination has also be done in other body fluids, secretions and excretions, for instance serum, plasma or urine. The Calprotectin concentrations and protocols vary and have to be performed according to the published methods (e.g., Johne et al., 1997). The CALPRO Calprotectin ELISA Test (ALP) has only been validated for stool samples. In patients under treatment a normal Calprotectin value is an indicator that mucosal healing has been achieved. The test can also be used to predict clinical relapses. Functional disorders like irritable bowel disease, do not give increased faecal Calprotectin concentrations.